Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers

Por Ericsson, H, Fakt, C, Jolin-Mellgård, Å, Nordlander, M, Sohtell, L, Sunzel, M, Regårdh, C G
Publicado em 1999